Brain scans reveal hidden effects of proton therapy in kids
NCT ID NCT05288439
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how proton beam radiation affects brain networks and thinking in children and young adults (ages 6-25) treated for brain tumors. Researchers will use special MRI scans taken at rest, along with thinking tests and quality-of-life questionnaires, to compare patients with healthy volunteers. The goal is to understand if radiation causes changes in brain connections that may affect memory or attention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Mar 2022
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients Treated for Brain Tumors: * The patient has been diagnosed with a primary or metastatic brain tumor * The patient has been recommended to receive cranial PBRT for a primary or metastatic brain tumor * The patient is between the ages of 6 through 25 at time of consent * As per medical record or patient report (based on prior tolerance of MRI), the participant is able to tolerate MRI without sedation (i.e., general anesthesia). Patients will take medications as prescribed or directed by the patient's physician. If in accordance with their prescribed regimen, agents that may impact the CNS, such as benzodiazepines and/or antihistamines, should be avoided on the day of imaging and neurocognitive assessment. Healthy Control Participants: * The control has no major medical illness, as determined by medical interview by study physician * As per parent report, the control is between the ages of 6 through 25 at time of consent * As per parent report, the control is able to tolerate an MRI without sedation (i.e., general anesthesia). Participants should only take medications as prescribed or directed by their physician. They should not take additional medications, such as antihistamines, for the purpose of tolerating MR imaging. Exclusion Criteria: * As per self or parent report, the participant has completed any portion of the neuropsychological battery used in this study within the last year. * As per medical record or self or parent report, there is an existing diagnosis of intellectual disability and/or prior IQ testing that documents Full Scale IQ standard score \<70 at baseline. * As per medical record, there is an existing diagnosis of psychiatric disorder or untreated mood disturbance, prior stroke or intracranial hemorrhage, or neurodegenerative disease. * The participant has an MRI contraindication (e.g., implanted ferromagnetic devices, claustrophobia) as per radiology clinical operating procedures. * As per self or parent report, non-fluency in English language as demonstrated by current educational placement in a non-English-speaking classroom setting.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore lost vision
- Brain surgery delirium: can real-time monitoring protect older patients?
- Music as medicine: could ukulele lessons rebuild young brains after cancer?
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds